Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1469751 | 0.84 | CA2 (0.38) | CA2CA1CA7CA13TSHR | |
| SCHEMBL1721980 | 0.80 | CA1 (0.35) | CA2CA1CA7CA13TSHR | |
| SCHEMBL10455410 | 0.79 | — | — | |
| SCHEMBL584563 | 0.79 | — | — | |
| SCHEMBL156570 | 0.79 | CA2 (0.42) | CA2CA1CA7CA13MMP1 | |
| SCHEMBL1550217 | 0.79 | CA2 (0.31) | CA2CA1CA7CA13 | |
| SCHEMBL867361 | 0.77 | CA2 (0.39) | CA2CA1CA7CA13MMP1 | |
| SCHEMBL103406 | 0.77 | CA2 (0.33) | CA2CA1CA7CA13MMP1 | |
| SCHEMBL73684 | 0.76 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL14837441 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116534813-A | Synthesis method of fluoro bis (sulfonyl) iminolithium compound | 河北圣泰材料股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-115602925-A | Electrolyte and battery comprising same | 珠海冠宇电池股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114709564-A | Battery diaphragm and preparation method and application thereof | 浙江极氪智能科技有限公司 | 2022-07-05 | — | — | CN | claimed |
| US-20210159541-A1 | ELECTROLYTE FOR LITHIUM BATTERY AND LITHIUM BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2021-05-27 | — | — | US | claimed |
| CN-110870126-A | Electrolyte for lithium battery and lithium battery including the same | 三星SDI株式会社 | 2020-03-06 | — | — | CN | claimed |
| CN-107098833-A | Surfactant based on perfluoro butyl and preparation method thereof | 中国民用航空飞行学院 | 2017-08-29 | — | — | CN | claimed |
| US-9434698-B2 | Process for preparing antiviral compounds | ABBVIE INC. (US) | 2016-09-06 | — | — | US | claimed |
| US-20150191437-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | ABBVIE INC. (US) | 2015-07-09 | — | — | US | claimed |
| US-20130224149-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | ABBVIE INC. (US) | 2013-08-29 | — | — | US | claimed |
| EP-1568725-B1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS SPA (IT) | 2008-06-18 | — | — | EP | claimed |
| US-7371900-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2008-05-13 | — | — | US | claimed |
| EP-1501792-B1 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M INNOVATIVE PROPERTIES CO (US) | 2007-02-14 | — | — | EP | claimed |
| US-20050197469-A1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. | 2005-09-08 | — | — | US | claimed |
| EP-1568725-A1 | Peroxidic perfluoropolyethers | Solvay Solexis S.p.A. (IT) | 2005-08-31 | — | — | EP | claimed |
| EP-1501792-A2 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M Innovative Properties Company (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003095422-A2 | CATALYTIC PROCESS FOR PREPARING PERFLUOROETHANESULFONYL FLUORIDE AND/OR PERFLUORODIETHYLSULFONE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-11-20 | — | — | WO | claimed |
| US-6580006-B1 | Reacting tetrafluoroethylene and sulfuryl fluoride in presence of metal fluoride and crown ether | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-17 | — | — | US | claimed |
| US-20010031891-A1 | Process for producing perfluoroalkanesulfinate | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-10-18 | — | — | US | claimed |
| CN-121726673-A | Preparation method and application of perfluorosulfonic acid polymer emulsion | 南京大学 | 2026-03-24 | — | — | CN | disclosed |
| US-3954828-A | Perfluoroalkanesulfonate ester herbicides | Fridinger, Tomas L. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130224149-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | HAVCR2, RNASE1, MAVS | CA2 4346/4885CA1 4130/4885CA7 3225/4885 |
| US-20050197469-A1 | Peroxidic perfluoropolyethers | PRDX2, PRDX1, PRXL2A | CA2 737/4885CA1 758/4885CA7 1474/4885 |
| US-20150191437-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | HAVCR2, RNASE1, MAVS | CA2 4346/4885CA1 4130/4885CA7 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.